How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
Koch Institute
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
How the immune system fights off malaria
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
Ludwig Cancer Research gives $90 million to MIT
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Researchers unlock a new means of growing intestinal stem cells
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Better batteries through biology?
MIT researchers find a way to boost lithium-air battery performance, with the help of modified viruses.
Finding blood clots before they wreak havoc
Simple urine test developed by MIT engineers uses nanotechnology to detect dangerous blood clotting.
New view of dengue fever
Mice with human immune cells help researchers discover how the mosquito-borne virus depletes blood platelets.
Nanoparticle vaccine offers better protection
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
New way to target an old foe: malaria
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines.
Grad student receives grant for melanoma research
David Benjamin will investigate mechanisms that melanoma cells use to spread to distant sites throughout the body
A step closer to artificial livers
Researchers identify compounds that help liver cells grow outside the body.
Study IDs key protein for cell death
Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
Grant to fund nanotech therapies for traumatic brain injuries
MIT’s Sangeeta Bhatia is part of the research team funded by the $6 million DARPA grant.